Yahoo
HKSE - Delayed Quote HKD

Innovent Biologics, Inc. (1801.HK)

79.750 -1.850 (-2.27%)
At close: October 30 at 4:08:06 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
15,706,230
13,041,523
9,421,888
6,206,070
4,556,380
Cost of Revenue
2,218,611
1,756,019
1,510,210
1,136,266
930,990
Gross Profit
13,487,619
11,285,504
7,911,678
5,069,804
3,625,390
Operating Expense
10,729,313
9,144,591
7,653,559
5,979,014
6,207,275
Operating Income
2,758,306
2,140,913
258,119
-909,210
-2,581,885
Net Non Operating Interest Income Expense
545,313
359,088
355,807
354,213
87,839
Pretax Income
1,553,470
838,924
-78,621
-1,144,411
-2,170,469
Tax Provision
321,084
25,359
16,010
-116,498
8,801
Net Income Common Stockholders
1,232,386
813,565
-94,631
-1,027,913
-2,179,270
Diluted NI Available to Com Stockholders
1,232,386
813,565
-94,631
-1,027,913
-2,179,270
Basic EPS
0.70
0.48
-0.06
-0.66
-1.46
Diluted EPS
0.68
0.47
-0.06
-0.66
-1.46
Basic Average Shares
1,719,063.244
1,677,499.694
1,627,460.846
1,559,637.004
1,490,123.192
Diluted Average Shares
1,784,119.585
1,741,127.152
1,627,460.846
1,559,637.004
1,490,123.192
Total Expenses
12,947,924
10,900,610
9,163,769
7,115,280
7,138,265
Net Income from Continuing & Discontinued Operation
1,232,386
813,565
-94,631
-1,027,913
-2,179,270
Normalized Income
1,086,723.650
809,698.519
-211,664
-1,054,728.840
-2,183,141.500
Interest Income
604,568
438,686
423,454
452,837
189,537
Interest Expense
59,255
79,598
67,647
98,624
101,698
Net Interest Income
545,313
359,088
355,807
354,213
87,839
EBIT
1,612,725
918,522
-10,974
-1,045,787
-2,068,771
EBITDA
2,279,724
1,519,839
408,794
-660,684
-1,749,349
Reconciled Cost of Revenue
2,218,611
1,756,019
1,510,210
1,136,266
930,990
Reconciled Depreciation
666,999
601,317
419,768
385,103
319,422
Net Income from Continuing Operation Net Minority Interest
1,232,386
813,565
-94,631
-1,027,913
-2,179,270
Total Unusual Items Excluding Goodwill
183,613
3,987
156,044
29,855
5,162
Total Unusual Items
183,613
3,987
156,044
29,855
5,162
Normalized EBITDA
2,096,111
1,515,852
252,750
-690,539
-1,754,511
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
37,950.650
120.519
39,011
3,039.160
1,290.500
12/31/2022 - 10/31/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: